Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 35OTHER 27NIH 5NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia 183Precursor Cell Lymphoblastic Leukemia-Lymphoma 130Leukemia, Myeloid, Acute 95Leukemia, Lymphocytic, Chronic, B-Cell 56Lymphoma 53Congenital Abnormalities 42Burkitt Lymphoma 41Myelodysplastic Syndromes 32Leukemia, Myelomonocytic, Acute 30Leukemia, Monocytic, Acute 30Leukemia, Megakaryoblastic, Acute 29Lymphoma, Non-Hodgkin 28Leukemia, Erythroblastic, Acute 28Lymphoma, Follicular 25Leukemia, Biphenotypic, Acute 25Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24Lymphoma, Large B-Cell, Diffuse 24Lymphoma, B-Cell, Marginal Zone 23Lymphoma, Mantle-Cell 19Lymphoma, Large-Cell, Immunoblastic 19Leukemia, Myelomonocytic, Chronic 19Leukemia, Myeloid, Chronic-Phase 19Hematologic Neoplasms 19Hodgkin Disease 17Leukemia, Myelomonocytic, Juvenile 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Waldenstrom Macroglobulinemia 15Myeloproliferative Disorders 14Lymphoma, Large-Cell, Anaplastic 14Dendritic Cell Sarcoma, Interdigitating 13

Interventions

Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Bronchiolitis Obliterans Syndrome × Other hematologic neoplasm × Clear all
NCT04716075 2025-01-16

ACALLO

Polish Lymphoma Research Group

Phase 2 Completed
29 enrolled
LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual, Lymphoma, Mantle-Cell

NCT00800943 2008-12-03

CRC005

Chronic Lymphocytic Leukemia Research Consortium

Phase 2 Unknown
31 enrolled
LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡